The Antiplatelet activity of ketamine is mediated through suppression of phosphoinositide breakdown and an increase in cyclic GMP.

Type

article

Resource

J. Biomed Sci.():in pre-ss.

Date Issued

2004

Author(s)

許準榕

Chang; Y.; Chen; T.L.; Hsiao; G.; Shen; M.Y.; Lin; K.H.; Chou; D.S.; Lin; C.H.; Sheu; J.R.

Subjects

醫學科學研究所

期刊論文

URI

File(s)

Name

attachment.pdf

Size

62.81 KB

Format

Adobe PDF

Checksum

(MD5):9d39c4a74807a9f85b3fde6c91d34f89